| Identification | Back Directory | [Name]
Cyclopentanepropanoic acid, α-[(forMylhydroxyaMino)Methyl]-, 2-[5-fluoro-6-[(9aS)-hexahydropyrazino[2,1-c][1,4]oxazin-8(1H)-yl]-2-Methyl-4-pyriMidinyl]hydrazide, (αR)- | [CAS]
1152107-25-9 | [Synonyms]
GSK-322)
GSK132232
Lanopepden
GSK-1322322
LANOPEPDEN (GSK 1322322)
GSK-1322322
(Lanopepden
GSK-1322322(Lanopepden/GSK-322)
N-((R)-2-(Cyclopentylmethyl)-3-(2-(5-fluoro-6-((S)-hexahydropyrazino[2,1-c][1,4]oxazin-8(1H)-yl)-2-methylpyrimidin-4-yl)hydrazinyl)-3-oxopropyl)-N-hydroxyformamide
Cyclopentanepropanoic acid, α-[(forMylhydroxyaMino)Methyl]-, 2-[5-fluoro-6-[(9aS)-hexahydropyrazino[2,1-c][1,4]oxazin-8(1H)-yl]-2-Methyl-4-pyriMidinyl]hydrazide, (αR)- | [EINECS(EC#)]
629-881-5 | [Molecular Formula]
C22H34FN7O4 | [MDL Number]
MFCD20526985 | [MOL File]
1152107-25-9.mol | [Molecular Weight]
479.56 |
| Chemical Properties | Back Directory | [density ]
1.36±0.1 g/cm3(Predicted) | [storage temp. ]
Store at -20°C | [solubility ]
Soluble in DMSO | [form ]
Solid | [pka]
8.60±0.69(Predicted) | [color ]
Off-white to light yellow |
| Hazard Information | Back Directory | [Uses]
Lanopepden (GSK 1322322) is a peptidyl peptidase (PDF) inhibitor. Lanopepden inhibits PDF activity, preventing bacterial protein synthesis, thereby exerting antibacterial activity. Lanopepden is primarily effective against Gram-positive bacteria. Lanopepden is used in the study of acute bacterial skin and skin structure infections[1]. | [storage]
Store at -20°C | [References]
[1] Peyrusson F, et al. Cellular pharmacokinetics and intracellular activity of the novel peptide deformylase inhibitor GSK1322322 against Staphylococcus aureus laboratory and clinical strains with various resistance phenotypes: studies with human THP-1 monocytes and J774 murine macrophages. Antimicrob Agents Chemother. 2015 Sep;59(9):5747-60. DOI:10.1128/AAC.00827-15 |
|
|